Member consultations

Current open consultations

With your input, we can deliver RACP health policy priorities

Through policy and advocacy consultations, members bring specialty expertise and experiences to inform strong positions and clear actions.  

If you need assistance or have any queries, contact policy@racp.edu.au


Current Policy & Advocacy consultations

Member Feedback: Ahpra consultation on the draft Endorsement for scheduled medicines for pharmacists

Letter iconFeedback deadline | Tuesday 26 May COB

For Australian members only.

The Pharmacy Board of Australia (PBA) is proposing to endorse pharmacists to prescribe scheduled medicines. Your feedback in this consultation is vital to safeguard patients and the public.

Submit your feedback


Member Feedback: SafeWork Australia criteria for hazardous chemicals requiring health monitoring

Letter iconRSVP by Monday 10am, 11 May 2026.

For Australian members only.

SafeWork Australia (SWA) is reviewing the health monitoring requirements for hazardous chemicals under the model Work Health & Safety (WHS) laws. Key concerns are:

  • That health monitoring requirements are not clear, resulting in low monitoring rates.
  • Establishing criteria to determine which hazardous chemicals require monitoring (currently Schedule 14 to the model Regulations) and the process in which a chemical would be added to this list.

For more information and to view the documents you can comment on, click the button below.

Submit your feedback



Other ways to get involved

Make a valuable contribution to your profession, your community and the RACP by getting involved with the RACP’s Policy & Advocacy activities. Participation in Policy & Advocacy consultations, endorsements and College Policy & Advocacy Council can earn you CPD hours.

Contact us for more information.


P & A Library

See our approved position statements, policies, and submissions.

P & A Reports

Discover how your voice shapes policy and advocacy by reading our reports.

P & A Priorities

Find out more about our current priorities.

News and media releases

See our latest news and media releases.

Close overlay